Biological Psychiatry 1991-04-01

The effects of physostigmine infusion on patients with panic disorder.

M H Rapaport, S C Risch, J C Gillin, S Golshan, D Janowsky

文献索引：Biol. Psychiatry 29(7) , 658-64, (1991)

全文：HTML全文

摘要

Nine patients who met both DSM-III and RDC criteria for panic disorder and nine age-matched normal controls received infusions of physostigmine. The patients and normal controls did not differ in either their self-reported or the observer-reported ratings of anxiety, mood, or activation. The two subject groups also did not differ in blood pressure, pulse, or cortisol responses to physostigmine. Physostigmine did not provoke panic attacks in either the control or patients groups.

相关化合物

  • 水杨酸毒扁豆碱

相关文献：

Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats.

2012-12-01

[Behav. Brain Res. 235(2) , 231-43, (2012)]

Development and optimization of a sublingual tablet formulation for physostigmine salicylate.

2009-09-01

[Acta. Pharm. 59(3) , 301-12, (2009)]

Liquid chromatographic analysis of physostigmine salicylate and its degradation products.

1999-01-01

[J. Pharm. Biomed. Anal. 18(6) , 939-45, (1999)]

Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats.

1988-04-26

[Brain Res. 447(1) , 122-32, (1988)]

Toxicity study of continuous administration of physostigmine salicylate.

1988-11-01

[Pharmacol. Biochem. Behav. 31(3) , 627-31, (1988)]

更多文献...